SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-296117
Filing Date
2020-11-17
Accepted
2020-11-17 17:07:24
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d37294d424b5.htm 424B5 254725
2 GRAPHIC g37294g01d28.jpg GRAPHIC 32419
3 GRAPHIC g37294g25i24.jpg GRAPHIC 55942
4 GRAPHIC g37294g26o61.jpg GRAPHIC 112915
5 GRAPHIC g37294g79g55.jpg GRAPHIC 32429
  Complete submission text file 0001193125-20-296117.txt   571746
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222268 | Film No.: 201321952
SIC: 2834 Pharmaceutical Preparations